文献速递腹部技术与安全CT

基于瘦体重的肝脏CT对比剂注射方案:对比剂剂量优化

Lean body weight-based contrast injection protocol in liver CT: optimization of contrast medium dose.
PubMed 文献 · Radiol Med · 2024-12-30

前瞻性随机将150例临床需行腹部增强CT的患者按瘦体重碘剂量分为700、650、600 mgI/kg三组,最终145例可评估。700 mgI/kg组肝脏SNR、CNR及ΔHU均显著高于650和600 mgI/kg组,650与600 mgI/kg组间无显著差异;700 mgI/kg组主观图像质量、伪影及诊断信心评分最高。结论认为700 mgI/kg瘦体重碘剂量可获得最佳肝脏强化和更高图像质量。

要点

  • 按瘦体重700 mgI/kg给碘时肝脏SNR、CNR及ΔHU均显著高于650和600 mgI/kg方案。
  • 650与600 mgI/kg组间SNR、CNR及ΔHU无显著差异(均p=1)。
  • 700 mgI/kg组总体图像质量、伪影及诊断信心评分均最高(评分4,IQR 4-5)。

核心结论

  • 基于瘦体重的700 mgI/kg碘剂量可获得最佳肝脏强化,与较低对比剂剂量相比图像质量更高。

研究设计与样本

  • 前瞻性随机对照研究,150例临床需行腹部增强CT的患者随机分入A组700 mgI/kg瘦体重、B组650 mgI/kg瘦体重、C组600 mgI/kg瘦体重,最终145例纳入分析(A组50例、B组48例、C组47例,其中女性64例)。

关键影像表现/征象

  • A组肝脏SNR、CNR及ΔHU均显著高于B组(分别为p=.018、p=.004、p=.031)。
  • A组肝脏SNR、CNR及ΔHU均显著高于C组(分别为p=.024、p=.043、p=.004)。
  • B组与C组肝脏SNR、CNR及ΔHU相似(均p=1)。
  • ΔHU<50 HU者A组2例(48.2±0.1)、B组7例(43.7±5)、C组11例(44.4±5)。
  • A组总体图像质量、伪影及诊断信心评分均为4(IQR 4-5),高于B组(均为3,IQR 3-5;p≥.037)和C组(总体图像质量3,IQR 2-5,p=.011;伪影及诊断信心3,IQR 1-4,p≥.009)。

诊断标准与关键数值

  • 以瘦体重为基准的碘剂量方案:A组700 mgI/kg、B组650 mgI/kg、C组600 mgI/kg。
  • 客观指标包括肝脏信噪比(SNR)、对比噪声比(CNR)及强化幅度(ΔHU)。
  • 主观图像质量采用5点Likert量表评估总体图像质量、伪影及诊断信心。

临床应用与阅片要点

  • 按瘦体重计算碘剂量时,700 mgI/kg较650和600 mgI/kg可获得更高的肝脏SNR、CNR及ΔHU。
  • 700 mgI/kg方案下ΔHU<50 HU者仅2例,而650和600 mgI/kg方案分别为7例和11例。
  • 700 mgI/kg方案的主观总体图像质量、伪影及诊断信心评分均最高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate liver enhancement and image quality of abdominal CECT examinations acquired with multiple LBW-based contrast medium injection protocols.

MATERIAL & METHODS: One hundred fifty patients who underwent a clinically indicated CECT examination were prospectively and randomly assigned to one of the following contrast medium injection protocol groups: A, 700 mg iodine(I)/kg of LBW; B, 650 mgI/kg of LBW; and C, 600 mgI/kg of LBW. Liver signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and magnitude of contrast enhancement (ΔHU) were calculated. Subjective image quality was assessed with 5-point Likert scale.

RESULTS: The final population included 145 patients (64 females), with 50, 48, and 47 in group A, B, and C, respectively. Group A showed significantly higher SNR, CNR and ΔHU than group B (p = .018, p = .004, and p = .031, respectively) and group C (p = .024, p = .043, and p = .004). Group B had similar SNR, CNR, and ΔHU to group C (all p = 1). ΔHU was < 50 HU in 2, 7, and 11 patients in group A (48.2 ± 0.1), B (43.7 ± 5), and C (44.4 ± 5), respectively. Group A achieved the highest scores in terms of overall image quality, artifacts, and diagnostic confidence (both scores: 4; IQRs: 4-5) compared to group B (both scores: 3; IQRs: 3-5; p ≥ .037) and group C (overall image quality score: 3; IQR: 2-5; p = .011. Artifact and diagnostic confidence score: 3; IQR: 1-4; p ≥ .009).

CONCLUSIONS: A dosage of 700 mgI/kg of LBW yields optimal liver enhancement and grants higher image quality compared to lower contrast medium dosages.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Caruso D, De Santis D, Del Gaudio A, et al. Lean body weight-based contrast injection protocol in liver CT: optimization of contrast medium dose. Radiol Med. 2024. PMID: 39738873. doi:10.1007/s11547-024-01944-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。